4//SEC Filing
Rubin Eyal 4
Accession 0001144204-19-045806
CIK 0001006281other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:01 PM ET
Size
5.8 KB
Accession
0001144204-19-045806
Insider Transaction Report
Form 4
Rubin Eyal
Sr. VP & CFO
Transactions
- Award
Stock Options (Right to Buy)
2019-09-22+800,000→ 800,000 totalExercise: $0.20Exp: 2029-09-22→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the stock options shall vest in 16 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., 2006 Stock Incentive Plan, as amended.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001721411
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 5:01 PM ET
- Size
- 5.8 KB